Showing results (1-10 of 164) with videos related to
Sort By:
Pageof 17
Nature Reviews. Drug Discovery|August 2, 2007
Embryonic stem cells as a source of models for drug discoveryColin W Pouton, John M HaynesAdvanced Drug Delivery Reviews|November 18, 2005
Pharmaceutical applications of embryonic stem cellsColin W Pouton, John M HaynesPlos One|March 3, 2012
In vitro maturation of dopaminergic neurons derived from mouse embryonic stem cells: implications for transplantationBradley Watmuff, Colin W Pouton, John M HaynesStem Cells (Dayton, Ohio)|April 8, 2011
Directed expression of Gata2, Mash1, and Foxa2 synergize to induce the serotonergic neuron phenotype during in vitro differentiation of embryonic stem cellsChristian M Nefzger, John M Haynes, Colin W PoutonFrontiers in Cell and Developmental Biology|February 23, 2023
TGFβ3, dibutyryl cAMP and a notch inhibitor modulate phenotype late in stem cell-derived dopaminergic neuron maturationShanti Sibuea, Joan K Ho, Colin W Pouton, et al.The European Journal of Neuroscience|April 11, 2007
Heterogeneous population of dopaminergic neurons derived from mouse embryonic stem cells: preliminary phenotyping based on receptor expression and functionWarren S Raye, Nathalie Tochon-Danguy, Colin W Pouton, et al.Plos One|November 7, 2013
DNA-dependent protein kinase is a context dependent regulator of Lmx1a and midbrain specificationCameron P Hunt, Stewart A Fabb, Colin W Pouton, et al.Neurochemistry International|June 1, 2011
Extended periods of neural induction and propagation of embryonic stem cell-derived neural progenitors with EGF and FGF2 enhances Lmx1a expression and neurogenic potentialWendy R Zeng, Stewart R A Fabb, John M Haynes, et al.Journal of Pharmacological and Toxicological Methods|December 1, 2009
Troubleshooting immunohistochemical labelling of proliferating cell nuclear antigen (PCNA) in cryocut tissue sections of mouse prostateJin Han Xie, Frédéric Hollande, John M Haynes, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 4, 2006
Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification systemColin W PoutonPageof 17